IRIS
MARZIONI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.175
EU - Europa 4.629
AS - Asia 4.108
SA - Sud America 1.094
AF - Africa 217
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
Totale 20.239
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.029
SG - Singapore 1.300
VN - Vietnam 943
BR - Brasile 845
RU - Federazione Russa 841
CN - Cina 668
UA - Ucraina 667
IT - Italia 623
IE - Irlanda 444
DE - Germania 412
SE - Svezia 402
HK - Hong Kong 364
FR - Francia 322
GB - Regno Unito 224
DK - Danimarca 223
FI - Finlandia 217
TR - Turchia 203
KR - Corea 117
IN - India 114
BD - Bangladesh 93
AR - Argentina 79
CA - Canada 75
CI - Costa d'Avorio 59
MA - Marocco 59
NL - Olanda 52
PL - Polonia 49
EC - Ecuador 46
IQ - Iraq 46
MX - Messico 46
JP - Giappone 45
ES - Italia 44
ID - Indonesia 43
ZA - Sudafrica 42
CO - Colombia 36
PY - Paraguay 25
BE - Belgio 24
VE - Venezuela 24
AT - Austria 21
UZ - Uzbekistan 20
PH - Filippine 19
PK - Pakistan 19
CL - Cile 17
TN - Tunisia 16
SA - Arabia Saudita 13
JO - Giordania 12
TH - Thailandia 12
LT - Lituania 10
PE - Perù 10
RO - Romania 10
AZ - Azerbaigian 9
UY - Uruguay 9
DZ - Algeria 8
EG - Egitto 8
IL - Israele 8
RS - Serbia 8
AE - Emirati Arabi Uniti 7
ET - Etiopia 6
EU - Europa 6
KE - Kenya 6
LB - Libano 6
TW - Taiwan 6
IR - Iran 5
MY - Malesia 5
AO - Angola 4
BY - Bielorussia 4
CH - Svizzera 4
HN - Honduras 4
PS - Palestinian Territory 4
AL - Albania 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
KZ - Kazakistan 3
MN - Mongolia 3
NI - Nicaragua 3
NP - Nepal 3
OM - Oman 3
SN - Senegal 3
BG - Bulgaria 2
BO - Bolivia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
KG - Kirghizistan 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 20.218
Salva come PNG Salva come JPEG
Città #
Ashburn 1.478
Chandler 764
Singapore 747
Jacksonville 697
Dallas 647
Fairfield 592
San Jose 453
Dublin 443
Des Moines 430
Boardman 391
Hong Kong 346
Ho Chi Minh City 287
Woodbridge 277
Wilmington 276
Houston 268
New York 265
The Dalles 231
Hanoi 230
Seattle 225
Cambridge 207
Centro 202
Los Angeles 193
Lauterbourg 170
Lawrence 161
Princeton 160
San Mateo 148
Moscow 129
Ann Arbor 124
Beijing 122
Hefei 83
San Diego 83
Council Bluffs 78
Munich 77
São Paulo 69
Chicago 67
Helsinki 66
Orem 66
Buffalo 64
Abidjan 59
Washington 58
London 55
Da Nang 51
Haiphong 46
Santa Clara 43
Turku 41
Warsaw 39
Guangzhou 36
Rio de Janeiro 34
Shanghai 32
Ancona 31
Tokyo 31
Turin 31
Brooklyn 29
Montreal 29
Nuremberg 28
Denver 27
Chennai 26
Johannesburg 26
Wuhan 23
Baghdad 22
Rome 21
Salt Lake City 21
Milan 20
Columbus 19
Hải Dương 19
Pune 19
Brussels 18
Frankfurt am Main 18
Guayaquil 18
Stockholm 18
Ankara 17
Atlanta 17
Norwalk 17
Poplar 17
Manchester 16
Marche 16
Tashkent 16
Mexico City 15
Toronto 15
Brasília 14
City of London 14
Elk Grove Village 14
Phoenix 14
Porto Alegre 14
Thái Nguyên 14
Wuxi 14
Salvador 13
Bắc Ninh 12
Can Tho 12
Jiaxing 12
Salamanca 12
Curitiba 11
Dhaka 11
Quito 11
Quận Ba 11
Tampa 11
Vienna 11
Amsterdam 10
Belo Horizonte 10
Torre Annunziata 10
Totale 12.705
Salva come PNG Salva come JPEG
Nome #
Use of nailfold capillaroscopy for the early diagnosis of systemic sclerosis in patients with primary biliary cholangitis 216
Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: a large retrospective cross-sectional study. 198
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 194
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury 186
HDL cholesterol protects from liver injury in mice with intestinal specific LXRα activation 181
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes 168
Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes 166
Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury. 166
H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. 165
Aging and the Biological Response to Liver Injury 164
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. 163
An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma. 162
Exendin-4 restores ppar-alpha and ppar-gamma activity in nash and reduces insulin resistance, pro-inflammatory mediators and total fatty acid content 160
Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis 160
Shear wave elastography and transient elastography in HCV patients after direct-acting antivirals 153
Aging-Related Molecular Pathways in Chronic Cholestatic Conditions 152
Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution 151
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 150
Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. 149
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 146
Clinical implications of novel aspects of biliary pathophysiology. 145
Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. 144
Leptin enhances cholangiocarcinoma cell growth. 144
Descriptive epidemiology of cholangiocarcinoma in Italy. 143
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 143
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) 142
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma 142
Gut-Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology 142
Functional and Structural Features of Cholangiocytes in Health and Disease 142
Administration of r-VEGF-A prevents hepatic artery ligation induced bile duct damage in bile duct ligated rats. 140
cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway 139
Hepatitis E in a region of Italy: An emerging autochthonous infection? 139
Exendin-4, a glucagon-like protein-1 receptor agonist, reduces proinflammatory conditions, and increases lipid oxidation and insulin sensitivity in hepatocytes from nonalcoholic steatohepatitis rats 138
Exendin-4, a Glucagon-Like Peptide 1 receptor agonist, protects cholangiocytes from apoptosis 138
Bile acid depletion and repletion regulate cholangiocyte proliferation and secretion in bile duct ligated rats through a phosphatidylinositol 3-kinase-dependent pathway. 137
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice 137
Cholangiocarcinoma development: the resurgence of bile acids 137
Bullous pemphigoid of Lever and celiac disease: a coincidental occurrence or an unusual association? 134
Current targets for Primary Sclerosing cholangitis 133
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 133
CAMP STIMULATES THE SECRETORY AND PROLIFERATIVE CAPACITY OF THE RAT BILIARY EPITHELIUM THROUGH CHANGES IN THE PKA/SRC/MEK/ERK1/2 PATHWAY 132
Increased local dopamine secretion has growth promoting effects in cholangiocarcinoma. 132
PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: Perspectives in the diagnosis of pancreatic cancer 131
Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. 130
Current and novel therapeutic opportunities for systemic therapy in biliary cancer 130
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 130
Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies 129
Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology 128
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation 128
Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic Acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts 127
Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis 127
Gastrin reverses established cholangiocyte proliferation and enhanced secretin-stimulated ductal secretion of BDL rats by activation of apoptosis through increased expression of Ca2+- dependent PKC isoforms. 127
Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models 126
Pancreatic Duodenal Homeobox-1 de novo expression drives cholangiocyte neuroendocrine-like transdifferentiation. 125
Selective inhibition of ion transport mechanisms regulating intracellular pH reduces proliferation and induces apoptosis in cholangiocarcinoma cells. 124
Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cells 124
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 122
Cholangiocarcinoma 2020: the next horizon in mechanisms and management 122
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. 121
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease. 121
Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret 121
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 120
Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin 118
Bile Acids in Polycystic Liver Diseases: Triggers of Disease Progression and Potential Solution for Treatment 118
Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy 118
Involvement of autophagy in ageing and chronic cholestatic diseases 117
Cariporide a selective Na+ /H+ exchange inhibitor, reduces PDGF-induced proliferation and oxidative stress product formation in rat hepatic stellate cells (HSC). 116
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 116
Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats 115
Serum micrornas as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 115
Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice 115
Selective Na+/H+ inhibition by cariporide reduces liver fibrosis in the rat 114
Glucagon-like Peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis 114
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 114
Role of apoptosis in development of primary biliary cirrhosis 113
Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies 113
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis 113
Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases 113
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis 113
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 113
Autocrine Regulation of Biliary Pathology by Activated Cholangiocytes. 112
Taurocholic acid feeding prevents tumor necrosis factor-alpha-induced damage of cholangiocytes by a PI3K-mediated pathway. 112
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis 112
Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat. 111
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 111
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach 111
Risk Stratification in Primary Biliary Cholangitis 110
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 109
The Impact of Radiofrequency Ablation on Survival Outcomes and Stent Patency in Patients with Unresectable Cholangiocarcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 108
Functional heterogeneity of the intrahepatic biliary tree 108
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis 108
Role of cholangiocytes in primary biliary cirrhosis 107
Primary Biliary Cholangitis: advances in management and treatment of the disease 106
Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database 106
The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice 105
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report 104
Cholangiocyte injury and ductopenic syndromes. 104
The management of cholestatic liver diseases: Current therapies and emerging new possibilities 104
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 103
The significance of genetics for cholangiocarcinoma development 103
Totale 13.141
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.737
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021373 0 0 0 0 0 0 0 0 0 0 226 147
2021/20221.351 71 341 19 36 14 68 79 83 67 98 219 256
2022/20232.495 212 202 140 188 154 616 4 160 600 13 159 47
2023/20241.519 246 33 118 302 241 326 16 29 11 27 10 160
2024/20252.771 317 277 103 45 82 115 159 96 702 206 282 387
2025/20268.106 501 450 695 1.099 840 573 1.451 828 723 740 206 0
Totale 20.694